F.D.A.’s Approval of Drug for Autism Upends Review Process

F.D.A.’s Approval of Drug for Autism Upends Review Process

Curated from NYT > Business — Here’s what matters right now:

The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.

Next step: Keep your day-to-day compliant and secure—find privacy-forward devices that help you stay protected.

Original reporting: NYT > Business

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.